Coeptis completes reverse merger with Z Squared; shares to trade as ZSQR April 27

Z Squared Inc.

Coeptis Therapeutics completes business combination with computing infrastructure firm Z Squared Inc.
Combined entity renamed Z Squared Inc.; shares to trade on Nasdaq Global Market under ZSQR starting April 27, 2026.
Prior to close, Coeptis distributed its biopharmaceutical business to its stockholders via pro rata distribution.
Post-merger: ~51.5M shares outstanding; former Z Squared stockholders own ~85%, legacy Coeptis holders own ~15%.
Z Squared COO cites vertically integrated platform across three states with dynamic power management and hardware lifecycle program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.